March 2023 Foundation eNews

lesturnerFoundation eNews, Home Page

Foundation News FDA Advisory Committee meeting on tofersen, an SOD1-ALS treatment set for March 22  The U.S. Food and Drug Administration (FDA) will hold an advisory committee meeting on March 22 to review Biogen’s New Drug Application (NDA) for accelerated …

February 2023 Foundation eNews

lesturnerFoundation eNews, Home Page

Foundation News Calming the destructive cells of ALS One of the reasons that ALS can progress quickly is that certain types of cells in the human body will attack diseased upper motor neurons, which are needed to initiate movement. Once …

2022 Impact Report

lesturnerFoundation Blog, Home Page, Research News

Your support of the Les Turner ALS Foundation is felt by people living with ALS, caregivers, families and loved ones everywhere. By making a donation or volunteering your time, you helped ensure they had the support they needed – and …